Dr. Modi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5841 S. Maryland Ave.
MC 6038
Chicago, IL 60637Phone+1 773-834-7831
Summary
- Parth K. Modi, MD, MS, is a fellowship-trained urologic oncologist with expertise in the management of genitourinary cancers, including bladder, prostate and kidney cancer. Dr. Modi also specializes in complex open and robotic surgery to treat patients with urologic cancers.
In addition to a dedication to his clinical practice, Dr. Modi is a committed researcher. His current research focuses on health care policy and improving the delivery of health care in the United States. His work has been funded by the National Cancer Institute and published in 45 peer-reviewed manuscripts, as well as numerous book chapters and presentations.
Education & Training
University of Michigan Health SystemFellowship, Minimally Invasive Urologic Surgery, 2017 - 2020
Rutgers Health/Robert Wood Johnson Medical SchoolResidency, Urology, 2013 - 2017
Rutgers Health/Robert Wood Johnson Medical SchoolResidency, Surgery, 2011 - 2013
Northwestern University The Feinberg School of MedicineClass of 2011
Certifications & Licensure
IN State Medical License 2023 - 2025
MI State Medical License 2017 - 2021
NJ State Medical License 2014 - 2017- American Board of Urology Urology
Publications & Presentations
PubMed
- 32 citationsUreteral Stent-Associated Pain: A ReviewChristopher Koprowski, Christopher Kim, Parth K. Modi, Sammy Elsamra
Journal of Endourology. 2016-07-11 - 10 citationsSafety of Robot-Assisted Radical Prostatectomy with Pneumoperitoneum of 20 mm Hg: A Study of 751 Patients.Parth K. Modi, Young Suk Kwon, Neal Patel, Michael Dinizo, Nicholas J. Farber
Journal of Endourology. 2015-10-05 - 65 citationsRenal cell carcinoma: the search for a reliable biomarker.Nicholas J. Farber, Christopher Kim, Parth K. Modi, Jane D Hon, Evita Sadimin
Translational Cancer Research. 2017-05-24
Journal Articles
- Trends and Outcomes of Lymphadenectomy for Nonmetastatic Renal Cell Carcinoma: A Propensity Score-Weighted Analysis of the National Cancer DatabaseParth K Modi, Tina M Mayer, Isaac Y Kim, Sammy E Elsamra, Thomas L Jang, Eric A Singer, Urologic Oncology
Authored Content
- Tradeoffs in Refining the Diagnosis of Prostate CancerJuly 2018
Professional Memberships
- Member
- Society of Urologic OncologyMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
